Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingsong He

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
BMC Cancer|January 11, 2017
Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myelomaXiaoyan Han, Lijuan Wang, Hongfei Shi, et al.
Plos One|October 4, 2016
Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaMingming Zhang, Huarui Fu, Xiaoyu Lai, et al.
Oxidative Medicine and Cellular Longevity|September 4, 2020
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/<i>β</i>-Catenin Signaling PathwaysXiuhua Wu, Yang Liu, Enfan Zhang, et al.
Cell Death & Disease|March 3, 2022
NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myelomaXi Huang, Wen Cao, Shunnan Yao, et al.
Annals of Hematology|August 22, 2015
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patientsYinjun Lou, Yafang Ma, Jianai Sun, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 31, 2018
HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repairXing Guo, Donghua He, Enfan Zhang, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 24, 2022
The Clinical Characteristics and Prognosis of Chinese Patients with Light-Chain Amyloidosis: A Retrospective Multicenter AnalysisDonghua He, Fangshu Guan, Minli Hu, et al.
Journal of Zhejiang University. Science. B|November 15, 2022
High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myelomaXiaoyan Yue, Linlin Huang, Yang Yang, et al.
Cancer Immunology, Immunotherapy : CII|July 26, 2022
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myelomaHaimeng Yan, Donghua He, Jianwei Qu, et al.
Cell Death & Disease|October 16, 2019
CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myelomaRuyi Xu, Yi Li, Haimeng Yan, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
BMC Cancer|January 11, 2017
Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myelomaXiaoyan Han, Lijuan Wang, Hongfei Shi, et al.
Plos One|October 4, 2016
Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaMingming Zhang, Huarui Fu, Xiaoyu Lai, et al.
Oxidative Medicine and Cellular Longevity|September 4, 2020
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/<i>β</i>-Catenin Signaling PathwaysXiuhua Wu, Yang Liu, Enfan Zhang, et al.
Cell Death & Disease|March 3, 2022
NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myelomaXi Huang, Wen Cao, Shunnan Yao, et al.
Annals of Hematology|August 22, 2015
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patientsYinjun Lou, Yafang Ma, Jianai Sun, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 31, 2018
HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repairXing Guo, Donghua He, Enfan Zhang, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 24, 2022
The Clinical Characteristics and Prognosis of Chinese Patients with Light-Chain Amyloidosis: A Retrospective Multicenter AnalysisDonghua He, Fangshu Guan, Minli Hu, et al.
Journal of Zhejiang University. Science. B|November 15, 2022
High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myelomaXiaoyan Yue, Linlin Huang, Yang Yang, et al.
Cancer Immunology, Immunotherapy : CII|July 26, 2022
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myelomaHaimeng Yan, Donghua He, Jianwei Qu, et al.
Cell Death & Disease|October 16, 2019
CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myelomaRuyi Xu, Yi Li, Haimeng Yan, et al.
Pageof 16